1 enrolling by invitation. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow Triple Negative Breast Neoplasms: new trials by email Literature Review of Triple Negative Breast Neoplasms trials Research Report on Triple Negative Breast Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer（UPGRADE-TNBC） paclitaxel polymeric micelles + carboplatin + iparomilimab and tuvonralimab - Triple-Negative Breast Cancer (TNBC), Neoadjuvant Therapy | Phase 2 / Phase 3 | Enrolling by invitation | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 32 | 2025-07-21 | 2026-08-18 |
Breast Diseases (1) · Breast Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Carboplatin (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)
China (1)